E. M. Antman, M. Cohen, and P. J. Bernink, The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making, JAMA, vol.284, pp.835-842, 2000.

D. A. Morrow, E. M. Antman, and A. Charlesworth, TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy, Circulation, vol.102, pp.2031-2037, 2000.

C. B. Granger, R. J. Goldberg, and O. Dabbous, Global Registry of Acute Coronary Events Investigators. Predictors of hospital mortality in the global registry of acute coronary events, Arch Intern Med, vol.163, pp.2345-2353, 2003.

E. A. Amsterdam, N. K. Wenger, and R. G. Brindis, AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Circulation, vol.130, pp.2354-2394, 2014.

O. Interventions, P. T. Gara, F. G. Kushner, and D. D. Ascheim, ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, vol.61, pp.78-140, 2013.

B. Ibanez, S. James, and S. Agewall, ESC Guidelines for the management of acute myocardial infarction in patients presenting with STsegment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC), Eur Heart J, vol.39, pp.119-177, 2017.

T. Huynh, S. Kouz, and A. T. Yan, Canada Acute Coronary Syndrome Risk Score: a new risk score for early prognostication in acute coronary syndromes, Am Heart J, vol.166, pp.58-63, 2013.

K. A. Fox, G. Fitzgerald, and E. Puymirat, Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score, BMJ Open, vol.4, issue.2, p.4425, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01311315

E. A. Bohula, M. P. Bonaca, and E. Braunwald, Atherothrombotic risk stratification and the efficacy and safety of vorapaxar in patients with stable ischemic heart disease and previous myocardial infarction, Circulation, vol.134, pp.304-313, 2016.

D. A. Morrow, E. Braunwald, and M. P. Bonaca,

, Steering Committee and Investigators. Vorapaxar in the secondary prevention of atherothrombotic events, N Engl J Med, vol.366, pp.1404-1413, 2012.

B. M. Scirica, M. P. Bonaca, and E. Braunwald, Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2 P-TIMI 50 trial, Lancet, vol.380, pp.1317-1324, 2012.

E. A. Bohula, D. A. Morrow, and R. P. Giugliano, Atherothrombotic risk stratification and ezetimibe for secondary prevention, J Am Coll Cardiol, vol.69, pp.911-921, 2017.

J. Cambou, T. Simon, and G. Mulak, The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics, Arch Mal Coeur Vaiss, vol.100, pp.524-534, 2007.

M. Hanssen, Y. Cottin, and K. Khalife, French Registry on Acute ST-elevation and non ST-elevation Myocardial Infarction 2010. FAST-MI 2010, Heart Br Card Soc, vol.98, pp.699-705, 2010.

L. Belle, G. Cayla, and Y. Cottin, FAST-MI 2015 investigators. French Registry on Acute ST-elevation and non-ST-elevation Myocardial Infarction 2015 (FAST-MI 2015). Design and baseline data. Arch Cardiovasc Dis, vol.110, pp.366-378, 2017.

A. K. Rao, C. Pratt, and A. Berke, Thrombolysis in Myocardial Infarction (TIMI) Trial phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase, J Am Coll Cardiol, vol.11, pp.1-11, 1988.

W. D. Rosamond, L. E. Chambless, and G. Heiss, Twenty-two-year trends in incidence of myocardial infarction, coronary heart disease mortality, and case fatality in 4 US communities, Circulation, vol.125, pp.1848-1857, 1987.

W. J. Rogers, P. D. Frederick, and E. Stoehr, Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006, Am Heart J, vol.156, pp.1026-1034, 2008.

R. W. Yeh, S. Sidney, and M. Chandra, Population trends in the incidence and outcomes of acute myocardial infarction, N Engl J Med, vol.362, pp.2155-2165, 2010.

K. A. Fox, P. G. Steg, and K. A. Eagle, Decline in rates of death and heart failure in acute coronary syndromes, JAMA, vol.297, pp.1892-1900, 1999.

E. Puymirat, T. Simon, and G. Cayla, Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction), Circulation, vol.136, pp.1908-1919, 1995.

B. A. Williams, K. M. Chagin, and L. D. Bash, External validation of the TIMI risk score for secondary cardiovascular events among patients with recent myocardial infarction, Atherosclerosis, vol.272, pp.80-86, 2018.

M. P. Bonaca, D. L. Bhatt, and M. Cohen, Long-term use of ticagrelor in patients with prior myocardial infarction, N Engl J Med, vol.372, pp.1791-1800, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01934996

M. S. Sabatine, R. P. Giugliano, and A. C. Keech, Evolocumab and clinical outcomes in patients with cardiovascular disease, N Engl J Med, vol.376, pp.1713-1722, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01896445

E. Puymirat, M. Bonaca, and M. Fumery, Atherothrombotic risk stratification after acute myocardial infarction: The Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention in the light of the French Registry of Acute ST Elevation or non-ST Elevation Myocardial Infarction registries, SUPPORTING INFORMATION Additional supporting information may be found online in the Supporting, vol.42, pp.227-234, 2019.